Member Info for RorkesDrift

Looks likely - revenue = MKT cap.

Patience is a virtue (and a card game)

Bump

What's Spotify

Insert yellow winky emoji

Maybe accelerated stability?

If they are testing various options and it does sound has if there are compromises to be required then several prototypes will be options - have to work it and that just takes time

Not a material scientist

That thought has crossed my mind - I have other stocks but I'm conscious I'm 50% in here already. Wish you (and therefore me) every success

Thank you to R40 for posting.

I actually had best summer tune in the bingo.HOUSE.

Like everything Alastair says its like a scavenger hunt - drops clues and red herrings just to tease us. I'm thinking this is a nod that the PL75 triangle applies - on track but no quicker.

You can work out he next financials fairly easily - I worry that I am missing something. Looking to see impact of first acquisition whichnshoukd impact margins at same time exveptionals drop out.

Bump

They make it on another list

Affirmer
bloody spool chucker
Its not sensitivity
turdfat is (insert yet another exploitive)
Lickspittle
You to are on the list

Lab tests should !!!! Be very accurate but logistics are difficult - not everyone has a IKEA car park.

BAMS network could test every front line worker every day (whispers that was a guess)

Sir A
Great time to
Stop writing great time to
Why is google closing price different
Stop now Adam
Buys showing as sells
Friend of mine says

End of June
£48M
£3
£5
£50
Bentley
MM666 is a (insert different expletive)
Myles said so
Ken said so

Thank you - great spot

Not sure it will be the most accurate test (possibly if you only consider LFD).

IF we get a test then it will new because it is accurate enough - still think need to consider a strategy of multiple testing 3 days apart to reduce false negative (plus double sales)

https://giphy.com/explore/fishing-rod

I admit thinking same thing. Need kinetics course (again)

Anyways looks like Alastair is thinking along your lines

https://avacta.com/wp-content/uploads/2020/02/Avacta-Investor-Presentation-February-2020_v2.PDF

Slide 10. Market approval should be rapid (~3 years) because doxorubicin is an established drug

I don't want to argue against myself but 60 day survival was also greatly improved.

I hope you are right (whispers I don't think he is) - if we get there we get there and whats 12 months between opinions.

Insert confused big yellow emoji

Apolgies - no affimer

I was trying to make the point that if regulators let companies cut corners then it can end badly - both drugs have a place in therapy. Thalidomide I think is used to treat leprosy.

We are talking about using high doses of a pro-drug that get converted in a specific tissue. The proposition being this enables you to use higher doses.

That's fine if you give it to a rat and then sacrifice them. However, what you don't know is what happens to the drug after its been converted - has complicated pharmacy dynamics. Does it leach out into the systemic circulation where you are back to square 1, does it overwhelm liver metabolism, does it accumulate in other tissues. This then becomes more complicated because the issues you get using multiple course with dox might occur with pro-dox. Stefin A on which affirmers are based is also a biologically active molecule.
The differences in dose, the cardio toxicity, the FTIM nature makes me think (albeit with limited regulatory experience) that this is not a submit an library file on dox and hope that will do. We are also not condeming people to death - there are other treatments